From 11:00 pm to 12:00 pm EST ( 8:00 pm to 9:00 pm PST ) on January 6th, the website will be under maintenance. We are sorry for the inconvenience. Please arrange your schedule properly.
FITC-εAhx-HHV-2 Envelope Glycoprotein G (561-578) is a FITC labeled HHV-2 Envelope Glycoprotein G (561-578). HHV-2 Envelope Glycoprotein G (561-578) is an immunodominant region of glycoprotein G (gG-2) reactive with all herpes simplex (HSV-2) sera .
Wulfenioidin H (Compound 5) is a diterpenoid, exhibits activity against Zika virus (ZIKV) with an EC50 value 8.50 μM. Wulfenioidin H interferes with the replication of the ZIKV by inhibiting the expression of the ZIKV envelope (E) protein .
HCV-1 e2 Protein (484-499) is a peptide consisting of 16 amino acids. HCV-1 e2 Protein (484-499) is derived from the envelope 2 protein of hepatitis C virus in the sera from individuals with antibodies to HCV .
Tifuvirtide (T-1249) is a peptide human immunodeficiency virus type-1 (HIV-1) fusion inhibitor. Tifuvirtide is a synthetically designed hybrid retroviral envelope polypeptide. Tifuvirtide has antiretroviral activity. Tifuvirtide can be used for the research of HIV infection .
Trilobatin, a natural sweetener derived from Lithocarpus polystachyus Rehd , Trilobatin is an HIV-1 entry inhibitor targeting the HIV-1 Gp41 envelope . Neuroprotective effects . Trilobatin is also a SGLT1/2 inhibitor that selectively induces the proliferation of human hepatoblastoma cells .
Wulfenioidin F is a diterpenoid, that can be isolated from the whole plant of Orthosiphon wulfenioides. Wulfenioidin F exhibits activity against Zika virus (ZIKV) with an EC50 of 8.07 μM. Wulfenioidin F interferes with the replication of the ZIKV by inhibiting the expression of the ZIKV envelope (E) protein .
Fiztasovimab (NPC-21; EV2038) is a fully human IgG1λ mAb against human cytomegalovirus (hCMV). Fiztasovimab acts neutralizing activity by binding to the antigenic domain 1 of glycoprotein B on hCMVenvelope. Fiztasovimab inhibits cell-to-cell transmission of hCMV .
COE-PNH2 exhibits antibacterial activity against Mycobacterium abscessus (Mab) with MIC90 of 26 μM. COE-PNH2 affects the integrity of the bacterial envelope and mycomembrane. COE-PNH2 reveals intracelluar penetration without mitochondrial toxicity .
HCV-1 e2 Protein (554-569) is one of the main antigenic regions of HCV envelope 2 (e2) protein. The HCV-1 e2 Protein (554-569) contains a putative n-glycosylation site, which was previously thought to influence the immune recognition of e2 .
Nimbin is a intermediate limonoid isolated from Azadirachta. Nimbin prevents tau aggregation and increases cell viability. Nimbin is effective inhibits the envelope protein of dengue virus. Nimbin has anti-inflammatory, antipyretic, antifungal, antihistamine, antiseptic, antioxidant, anti-cancer and anti-viral properties. Nimbin can across blood-brain barrier .
HCV-1 e2 Protein (554-569) TFA is one of the main antigenic regions of HCV envelope 2 (e2) protein. The HCV-1 e2 Protein (554-569) TFA contains a putative N-glycosylation site, which was previously thought to influence the immune recognition of e2 .
Peniterphenyl A is a natural product obtained from a deep-sea-derived Penicillium sp. Peniterphenyl A inhibits HSV-1/2 virus entry into cells and may block HSV-1/2 infection through direct interaction with virus envelope glycoprotein D to interfere with virus adsorption and membrane fusion. Peniterphenyl A is a promising lead compound against HSV-1/2 .
N-(3-Oxopentanoyl)-L-homoserine lactone is an autoinducer, a kind of chemical signal molecule which passively diffuses across the bacterial envelope and accumulates intracellularly at high bacterial densities. It may bind to a protein related to the LuxR protein of V. fischeri and causes cell density-dependent gene expression. N-(3-Oxopentanoyl)-L-homoserine can be used for research of quorum sensing .
PARP11 inhibitor ITK7 (ITK7) is a potent and selective PARP11 inhibitor. PARP11 inhibitor ITK7 can potently inhibit PARP11 with an IC50 value of 14 nM. PARP11 inhibitor ITK7 can be used for the research of cellular localization . PARP11 inhibitor ITK7 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Stampidine is a nucleoside reverse transcriptase inhibitor (NRTI) with potent and broad-spectrum anti-HIV activity. Stampidine inhibits the laboratory HIV-1 strain HTLVIIIB (B-envelope subtype) and primary clinical isolates with IC50s of 1 nM and 2 nM, respectively. Stampidine also inhibits NRTI-resistant primary clinical isolates and NNRTI-resistant clinical isolates with IC50s of 8.7 nM and 11.2 nM, respectively .
Docusate Sodium (Dioctyl sulfosuccinate sodium salt) is one of the main components in stool softeners. Docusate Sodium is a sulfated surfactant and may inactivate viral pathogens by disrupting viral envelopes and/or denaturing/disassociating proteins. Docusate Sodium is effective in vitro against wild type and drug-resistant strains of HSV type 1 and 2. Docusate Sodium is an obesogen. Docusate Sodium with developmental exposure leads to increased adult adiposity, inflammation, metabolic disorder and dyslipidemia in offspring fed a standard diet in mice .
FITC-εAhx-HHV-2 Envelope Glycoprotein G (561-578) is a FITC labeled HHV-2 Envelope Glycoprotein G (561-578). HHV-2 Envelope Glycoprotein G (561-578) is an immunodominant region of glycoprotein G (gG-2) reactive with all herpes simplex (HSV-2) sera .
CKS-17 is a synthetic retroviral envelope peptide. CKS-17 has the highly conserved amino acid sequences occurring within the transmembrane envelope protein of many animal and human retroviruses. CKS-17 acts as an immunomodulatory epitope and exhibits suppressive properties for numerous immune functions .
HCV-1 e2 Protein (484-499) is a peptide consisting of 16 amino acids. HCV-1 e2 Protein (484-499) is derived from the envelope 2 protein of hepatitis C virus in the sera from individuals with antibodies to HCV .
Tifuvirtide (T-1249) is a peptide human immunodeficiency virus type-1 (HIV-1) fusion inhibitor. Tifuvirtide is a synthetically designed hybrid retroviral envelope polypeptide. Tifuvirtide has antiretroviral activity. Tifuvirtide can be used for the research of HIV infection .
Pentaglycine (Tetraglycylglycine) is a bridge containing five glycine molecules. Pentaglycine can form highly cross-linked peptidoglycan. Glucose reduced expression of pentaglycine. Pentaglycine is cleaved by lysostaphin, and occurs in the cell envelope of staphylococci .
HCV-1 e2 Protein (554-569) is one of the main antigenic regions of HCV envelope 2 (e2) protein. The HCV-1 e2 Protein (554-569) contains a putative n-glycosylation site, which was previously thought to influence the immune recognition of e2 .
HCV-1 e2 Protein (554-569) TFA is one of the main antigenic regions of HCV envelope 2 (e2) protein. The HCV-1 e2 Protein (554-569) TFA contains a putative N-glycosylation site, which was previously thought to influence the immune recognition of e2 .
Fiztasovimab (NPC-21; EV2038) is a fully human IgG1λ mAb against human cytomegalovirus (hCMV). Fiztasovimab acts neutralizing activity by binding to the antigenic domain 1 of glycoprotein B on hCMVenvelope. Fiztasovimab inhibits cell-to-cell transmission of hCMV .
Trilobatin, a natural sweetener derived from Lithocarpus polystachyus Rehd , Trilobatin is an HIV-1 entry inhibitor targeting the HIV-1 Gp41 envelope . Neuroprotective effects . Trilobatin is also a SGLT1/2 inhibitor that selectively induces the proliferation of human hepatoblastoma cells .
Wulfenioidin H (Compound 5) is a diterpenoid, exhibits activity against Zika virus (ZIKV) with an EC50 value 8.50 μM. Wulfenioidin H interferes with the replication of the ZIKV by inhibiting the expression of the ZIKV envelope (E) protein .
Wulfenioidin F is a diterpenoid, that can be isolated from the whole plant of Orthosiphon wulfenioides. Wulfenioidin F exhibits activity against Zika virus (ZIKV) with an EC50 of 8.07 μM. Wulfenioidin F interferes with the replication of the ZIKV by inhibiting the expression of the ZIKV envelope (E) protein .
Nimbin is a intermediate limonoid isolated from Azadirachta. Nimbin prevents tau aggregation and increases cell viability. Nimbin is effective inhibits the envelope protein of dengue virus. Nimbin has anti-inflammatory, antipyretic, antifungal, antihistamine, antiseptic, antioxidant, anti-cancer and anti-viral properties. Nimbin can across blood-brain barrier .
Peniterphenyl A is a natural product obtained from a deep-sea-derived Penicillium sp. Peniterphenyl A inhibits HSV-1/2 virus entry into cells and may block HSV-1/2 infection through direct interaction with virus envelope glycoprotein D to interfere with virus adsorption and membrane fusion. Peniterphenyl A is a promising lead compound against HSV-1/2 .
The NS1 protein plays a key role in viral budding, association with cell membranes, and facilitating the assembly of viral RNA into nucleocapsids to form mature viral particles. During entry, NS1 induces genome penetration into the host cytoplasm. E/Envelope Protein, Dengue virus 1 (101a.a, sf9, His) is the recombinant Virus-derived E/Envelope protein, expressed by Sf9 insect cells , with C-His labeled tag. The total length of E/Envelope Protein, Dengue virus 1 (101a.a, sf9, His) is 101 a.a., with molecular weight of ~12.4 kDa.
Enveloped small membrane proteins play a central role in viral morphogenesis and assembly, acting as viroporins that self-assemble in the host membrane to form homopentameric protein-lipid pores that facilitate ion transport. In addition to virus formation, it induces apoptosis and interacts with membrane protein M in the budding compartment of the host cell while binding to nuclear proteins. Envelope small membrane Protein, HCoV-NL63 (Cell-Free, His) is the recombinant Virus-derived Envelope small membrane protein, expressed by E. coli Cell-free , with N-10*His labeled tag. The total length of Envelope small membrane Protein, HCoV-NL63 (Cell-Free, His) is 77 a.a., with molecular weight of 12.0 kDa.
Envelope glycoprotein gp64 is classified as a class III viral fusion protein. As an envelope phosphate glycoprotein, it promotes the fusion of virus and host endosomal membranes, thereby promoting virus entry into host cells. Following receptor-mediated viral internalization, gp64 undergoes a conformational change at low pH into a fusion-competent state, thereby releasing the nucleocapsid into the host cell cytoplasm upon cell fusion. envelope glycoprotein gp64 Protein, AcmNPV (HEK293, His) is the recombinant Virus-derived envelope glycoprotein gp64 protein, expressed by HEK293 , with C-His labeled tag. The total length of envelope glycoprotein gp64 Protein, AcmNPV (HEK293, His) is 481 a.a., with molecular weight of ~54.2 KDa.
Envelope glycoprotein gp64 is classified as a class III viral fusion protein. As an envelope phosphate glycoprotein, it promotes the fusion of virus and host endosomal membranes, thereby promoting virus entry into host cells. Following receptor-mediated viral internalization, gp64 undergoes a conformational change at low pH into a fusion-competent state, thereby releasing the nucleocapsid into the host cell cytoplasm upon cell fusion. envelope glycoprotein gp64 Protein, AcmNPV (sf9, His) is the recombinant Virus-derived envelope glycoprotein gp64 protein, expressed by Sf9 insect cells , with C-His labeled tag. The total length of envelope glycoprotein gp64 Protein, AcmNPV (sf9, His) is 481 a.a., with molecular weight of ~54.2 KDa.
envelope glycoprotein gp120 Protein is a glycoprotein exposed on the surface of the HIV envelope. Gp120 is essential for viral infection as it facilitates HIV entry into the host cell. gp120 may also be facilitating viral persistence and continuing HIV infection by influencing the T cell immune response to the virus. envelope glycoprotein gp120 Protein, HIV-1 (ACY40659, HEK293, His) is the recombinant Virus-derived envelope glycoprotein gp120 protein, expressed by HEK293 , with C-His labeled tag. The total length of envelope glycoprotein gp120 Protein, HIV-1 (ACY40659, HEK293, His) is 490 a.a., with molecular weight of ~56.2 kDa.
envelope glycoprotein gp120 Protein is a glycoprotein exposed on the surface of the HIV envelope. Gp120 is essential for viral infection as it facilitates HIV entry into the host cell. gp120 may also be facilitating viral persistence and continuing HIV infection by influencing the T cell immune response to the virus. envelope glycoprotein gp120 Protein, HIV-1 (AFM77980, HEK293, His) is the recombinant Virus-derived envelope glycoprotein gp120 protein, expressed by HEK293 , with C-His labeled tag. The total length of envelope glycoprotein gp120 Protein, HIV-1 (AFM77980, HEK293, His) is 474 a.a., with molecular weight of 70-120 kDa.
ERVK-7 protein, a retroviral envelope protein, is crucial in early infection, mediating receptor recognition and membrane fusion. Evolutionarily, endogenous envelope proteins, like ERVK-7, may retain, lose, or modify functions. The SU domain of ERVK-7 is instrumental in receptor recognition, emphasizing its role in retroviral infection. This underscores the adaptability of retroviral envelope proteins over time. ERVK-7 Protein, Human (Cell-Free, His) is the recombinant human-derived ERVK-7 protein, expressed by E. coli Cell-free , with N-10*His labeled tag. The total length of ERVK-7 Protein, Human (Cell-Free, His) is 588 a.a., with molecular weight of 68.2 kDa.
envelope glycoprotein gp120 Protein is a glycoprotein exposed on the surface of the HIV envelope. Gp120 is essential for viral infection as it facilitates HIV entry into the host cell. gp120 may also be facilitating viral persistence and continuing HIV infection by influencing the T cell immune response to the virus. envelope glycoprotein gp120 Protein, HIV-1 (AAC57427, HEK293, His) is the recombinant Virus-derived envelope glycoprotein gp120 protein, expressed by HEK293 , with C-His labeled tag. The total length of envelope glycoprotein gp120 Protein, HIV-1 (AAC57427, HEK293, His) is 479 a.a., with molecular weight of ~55.4 kDa.
envelope glycoprotein gp120 Protein is a glycoprotein exposed on the surface of the HIV envelope. Gp120 is essential for viral infection as it facilitates HIV entry into the host cell. gp120 may also be facilitating viral persistence and continuing HIV infection by influencing the T cell immune response to the virus. envelope glycoprotein gp120 Protein, HIV-1 (AAA44191, HEK293, His) is the recombinant Virus-derived envelope glycoprotein gp120 protein, expressed by HEK293 , with C-10*His labeled tag. The total length of envelope glycoprotein gp120 Protein, HIV-1 (AAA44191, HEK293, His) is 480 a.a., with molecular weight of 95-150 kDa.
envelope glycoprotein gp120 Protein is a glycoprotein exposed on the surface of the HIV envelope. Gp120 is essential for viral infection as it facilitates HIV entry into the host cell. gp120 may also be facilitating viral persistence and continuing HIV infection by influencing the T cell immune response to the virus. envelope glycoprotein gp120 Protein, SIV (508a.a, HEK293, His) is the recombinant Virus-derived envelope glycoprotein gp120 protein, expressed by HEK293 , with C-His labeled tag. The total length of envelope glycoprotein gp120 Protein, SIV (508a.a, HEK293, His) is 508 a.a., with molecular weight of ~59.8 kDa.
The envelope glycoprotein gp120 protein facilitates viral capture and dissemination by dendritic cells and endothelial cells by attaching the virus to host lymphocytes through binding to the CD4 receptor. HIV exploits the migratory properties of dendritic cells to access CD4+ T cells, leading to infection. Envelope glycoprotein gp120 Protein, HIV (Q9DKG6, HEK293, His) is the recombinant Virus-derived Envelope glycoprotein gp120 protein, expressed by HEK293 , with C-8*His labeled tag. The total length of Envelope glycoprotein gp120 Protein, HIV (Q9DKG6, HEK293, His) is 498 a.a., with molecular weight of 105-130 kDa.
envelope glycoprotein gp120 Protein is a glycoprotein exposed on the surface of the HIV envelope. Gp120 is essential for viral infection as it facilitates HIV entry into the host cell. gp120 may also be facilitating viral persistence and continuing HIV infection by influencing the T cell immune response to the virus. envelope glycoprotein gp120 Protein, SIV (461a.a, HEK293, His) is the recombinant Virus-derived envelope glycoprotein gp120 protein, expressed by HEK293 , with C-His labeled tag. The total length of envelope glycoprotein gp120 Protein, SIV (461a.a, HEK293, His) is 461 a.a., with molecular weight of ~54.6 kDa.
Glycoprotein B (gB) is a key envelope glycoprotein that forms unique spikes on the surface of viral particles and plays a crucial role in the initial attachment of the heparan sulfate moiety of the host cell surface proteoglycan. This interaction is a fundamental step in the viral entry process. glycoprotein B/gB Protein, HHV-2 (Cell-Free, His) is the recombinant Virus-derived glycoprotein B/gB protein, expressed by E. coli Cell-free , with N-10*His labeled tag. The total length of glycoprotein B/gB Protein, HHV-2 (Cell-Free, His) is 882 a.a., with molecular weight of 99.7 kDa.
Glycoprotein B (gB) is an important envelope glycoprotein that forms spikes on the viral envelope and facilitates initial attachment to the heparan sulfate moiety on the host cell surface. gB is essential for viral entry and is involved in mediating fusion between the viral and cell membranes. glycoprotein B/gB Protein, HHV-7 (Cell-Free, His) is the recombinant Virus-derived glycoprotein B/gB protein, expressed by E. coli Cell-free , with N-10*His labeled tag. The total length of glycoprotein B/gB Protein, HHV-7 (Cell-Free, His) is 800 a.a., with molecular weight of 93.5 kDa.
Glycoprotein C (gC protein) is an important attachment protein that promotes virus binding to the cell surface by interacting with heparan sulfate or chondroitin sulfate. This critical role emphasizes its importance during the initial stages of viral infection. glycoprotein C/gC Protein, HHV-2 (Cell-Free, His) is the recombinant Virus-derived glycoprotein C/gC protein, expressed by E. coli Cell-free , with N-10*His labeled tag. The total length of glycoprotein C/gC Protein, HHV-2 (Cell-Free, His) is 453 a.a., with molecular weight of 50.5 kDa.
Glycoprotein D/gD proteins bind to host cell receptors TNFRSF14/HVEM and NECTIN1, triggering fusion with the host membrane by recruiting gB and gH/gL. glycoprotein D/gD Protein, HHV-2 (Cell-Free, His) is the recombinant Virus-derived glycoprotein D/gD protein, expressed by E. coli Cell-free , with N-10*His labeled tag. The total length of glycoprotein D/gD Protein, HHV-2 (Cell-Free, His) is 368 a.a., with molecular weight of 42.3 kDa.
Glycoprotein E/gE proteins bind to the host cell entry receptor IDE. glycoprotein E/gE Protein, HHV-3 (Cell-Free, His) is the recombinant Virus-derived glycoprotein E/gE protein, expressed by E. coli Cell-free , with N-10*His labeled tag. The total length of glycoprotein E/gE Protein, HHV-3 (Cell-Free, His) is 593 a.a., with molecular weight of 68.4 kDa.
Glycoprotein E (gE) is an important component of the viral envelope and binds to the host cell entry receptor IDE. gE/gI heterodimers are critical in epithelial cells and facilitate cell-to-cell viral spread by sorting nascent viral particles to cell junctions. glycoprotein E/gE Protein, HHV-3 (Cell-Free, His, SUMO) is the recombinant Virus-derived glycoprotein E/gE protein, expressed by E. coli Cell-free , with N-10*His, N-SUMO labeled tag. The total length of glycoprotein E/gE Protein, HHV-3 (Cell-Free, His, SUMO) is 593 a.a., with molecular weight of 85.4 kDa.
gp160 is an envelope glycoprotein that oligomerizes into major trimers in the host endoplasmic reticulum. gp160 is transported in the host Golgi apparatus to complete the glycosylation process. The precursors are proteolytic cleaved in the trans-Golgi apparatus to produce gp120 and gp41. envelope glycoprotein gp160 Protein, HIV-1 (AAT67478, HEK293, His) is the recombinant Virus-derived envelope glycoprotein gp160 protein, expressed by HEK293 , with C-His labeled tag. The total length of envelope glycoprotein gp160 Protein, HIV-1 (AAT67478, HEK293, His) is 464 a.a., with molecular weight of ~52.2 kDa.
Envelope Glycoprotein E1 Protein, one of two subunits of the envelope glycoprotein found in the hepatitis C virus, is a type 1 transmembrane protein. It associates with envelope glycoprotein E2 as a noncovalent heterodimer, which mediates virus attachment to the host cell, virion internalization through clathrin-dependent endocytosis and fusion with host membrane. E1/E2 heterodimer binds host apolipoproteins. And it also binds to CD81 and activates the epithelial growth factor receptor (EGFR) signaling pathway. Envelope Glycoprotein E1 Protein, HCV (HEK293, His) is the recombinant Virus-derived Envelope Glycoprotein E1 protein, expressed by HEK293 , with N-His labeled tag. The total length of Envelope Glycoprotein E1 Protein, HCV (HEK293, His) is 149 a.a., with molecular weight of ~18.7 kDa.
The glycoprotein G/gG protein, functioning as a chemokine-binding protein, critically modulates immune responses by inhibiting neutrophil chemotaxis. It prevents the migration of neutrophils in response to chemokine signals, contributing to the fine-tuned control of immune cell recruitment and positioning within tissues. This highlights the protein's significance in orchestrating the immune system and maintaining immune homeostasis. glycoprotein G/gG Protein, HHV-1 (Cell-Free, His) is the recombinant Virus-derived glycoprotein G/gG protein, expressed by E. coli Cell-free , with N-10*His labeled tag. The total length of glycoprotein G/gG Protein, HHV-1 (Cell-Free, His) is 214 a.a., with molecular weight of 28.8 kDa.
Glycoprotein E/gE proteins bind to gI and promote viral spread in epithelial cells by sorting viral particles to cell junctions. It is able to spread to neighboring cells through receptor interactions. glycoprotein E/gE Protein, HHV-2 (Cell-Free, His) is the recombinant Virus-derived glycoprotein E/gE protein, expressed by E. coli Cell-free , with N-10*His labeled tag. The total length of glycoprotein E/gE Protein, HHV-2 (Cell-Free, His) is 525 a.a., with molecular weight of 60.1 kDa.
GP2b Protein, a minor envelope protein, potentially acts as a viroporin, aiding virus uncoating for genomic RNA release into the cytoplasm. It forms homooligomers, creating higher-order structures like dimers, trimers, and tetramers. GP2b is likely part of the GP2a-GP3-GP4 complex, contributing to the overall functionality of the viral envelope. GP2b Protein, PRRSV (Cell-Free, His) is the recombinant Virus-derived GP2b protein, expressed by E. coli Cell-free , with N-10*His labeled tag. The total length of GP2b Protein, PRRSV (Cell-Free, His) is 69 a.a., with molecular weight of 13.7 kDa.
The gB Protein is an envelope glycoprotein that plays a role in host cell entry, cell-to-cell viral transmission, and infected cell fusion. gB Protein interacts with heparin sulfate proteoglycan and forms an association with gH/gL heterodimer. HCMV Glycoprotein B/gB Protein (HEK293, Fc) is a recombinant Virus-derived HCMV Glycoprotein B/gB protein(with cleavage site mutated RTKR to TTQT), expressed by HEK293 , with C-hFc labeled tag. HCMV Glycoprotein B/gB Protein (HEK293, Fc), has molecular weight of 160-170 kDa.
The Epstein-Barr viral glycoprotein gp350 (GP350) is critical for initiating attachment of viral particles to host B lymphocytes, a critical step in viral entry. By binding to host CR2 on B lymphocytes, GP350 promotes the subsequent binding of the viral glycoprotein gp42 to HLA class II molecules. Epstein-Barr virus Glycoprotein gp350/GP350 Protein (sf9, His) is the recombinant Virus-derived Epstein-Barr virus Glycoprotein gp350/GP350 protein, expressed by Sf9 insect cells , with C-His labeled tag. The total length of Epstein-Barr virus Glycoprotein gp350/GP350 Protein (sf9, His) is 490 a.a., with molecular weight of ~53.7 kDa.
The Epstein-Barr viral glycoprotein gp350 (GP350) is critical for initiating attachment of viral particles to host B lymphocytes, a critical step in viral entry. By binding to host CR2 on B lymphocytes, GP350 promotes the subsequent binding of the viral glycoprotein gp42 to HLA class II molecules. Epstein-Barr virus Glycoprotein gp350/GP350 Protein (HEK293, His) is the recombinant Virus-derived Epstein-Barr virus Glycoprotein gp350/GP350 protein, expressed by HEK293 , with C-His labeled tag. The total length of Epstein-Barr virus Glycoprotein gp350/GP350 Protein (HEK293, His) is 490 a.a., with molecular weight of ~53.7 kDa.
envelope glycoprotein gp120 Protein is a glycoprotein exposed on the surface of the HIV envelope. Gp120 is essential for viral infection as it facilitates HIV entry into the host cell. gp120 may also be facilitating viral persistence and continuing HIV infection by influencing the T cell immune response to the virus. envelope glycoprotein gp120 Protein, SIV (ADN41251, HEK293, His) is the recombinant Virus-derived envelope glycoprotein gp120 protein, expressed by HEK293 , with C-His labeled tag. The total length of envelope glycoprotein gp120 Protein, SIV (ADN41251, HEK293, His) is 509 a.a., with molecular weight of ~60 kDa.
The ERVW-1 protein is an endogenous retroviral envelope protein that retains fusogenic properties critical for trophoblast fusion and syncytium formation during placental morphogenesis. Its fusion ability involves binding to SLC1A4 and SLC1A5. ERVW-1 Protein, Human (His-SUMO) is the recombinant human-derived ERVW-1 protein, expressed by E. coli , with N-His, N-SUMO labeled tag. The total length of ERVW-1 Protein, Human (His-SUMO) is 423 a.a., with molecular weight of ~63.0 kDa.
Envelope glycoprotein gp160 Protein (HIV-1 gp160 Protein) is the sole antigenic protein on the surface of the HIV-1 virion and mediates HIV-1 entry into target cells. The endoproteolytic processing of HIV-1 gp160 membrane glycoprotein precursor into gp120 and gp41 is necessary for formation of infectious HIV particles. HIV-1 gp160 induces endothelial cell apoptosis, which is mediated by CXCR4 chemokine receptor. envelope glycoprotein gp160 Protein, HIV-1 (ADD25380, HEK293, His) is the recombinant Virus-derived envelope glycoprotein gp160 protein, expressed by HEK293 , with C-His labeled tag. The total length of envelope glycoprotein gp160 Protein, HIV-1 (ADD25380, HEK293, His) is 473 a.a., with molecular weight of ~54.4 KDa.
The envelope glycoprotein gp120 protein facilitates viral capture and dissemination by dendritic cells and endothelial cells by attaching the virus to host lymphocytes through binding to the CD4 receptor. HIV exploits the migratory properties of dendritic cells to access CD4+ T cells, leading to infection. envelope glycoprotein gp120 Protein, HIV-1 (AAC31819, HEK293, His) is the recombinant Virus-derived envelope glycoprotein gp120 protein, expressed by HEK293 , with C-His labeled tag. The total length of envelope glycoprotein gp120 Protein, HIV-1 (AAC31819, HEK293, His) is 484 a.a., with molecular weight of 95-130 kDa.
Genome polyprotein is a smaller protein chain of covalent linkages that is a key component of virus survival and replication. Zika virus E/Envelope Protein (HEK293, His) is the recombinant Virus-derived Zika virus E/Envelope protein, expressed by HEK293 , with C-His labeled tag. The total length of Zika virus E/Envelope Protein (HEK293, His) is 107 a.a., with molecular weight of ~13 kDa.
Genome polyprotein is a smaller protein chain of covalent linkages that is a key component of virus survival and replication. Zika virus E/Envelope Protein (438a.a, sf9, His) is the recombinant Virus-derived Zika virus E/Envelope protein, expressed by Sf9 insect cells , with C-His labeled tag. The total length of Zika virus E/Envelope Protein (438a.a, sf9, His) is 438 a.a., with molecular weight of ~49.3 kDa.
Genome polyprotein is a smaller protein chain of covalent linkages that is a key component of virus survival and replication. Zika virus E/Envelope Protein (Domain III, P.pastoris, His) is the recombinant Virus-derived Zika virus E/Envelope protein, expressed by P. pastoris , with C-His labeled tag. The total length of Zika virus E/Envelope Protein (Domain III, P.pastoris, His) is 107 a.a., with molecular weight of ~13 kDa.
Genome polyprotein is a smaller protein chain of covalent linkages that is a key component of virus survival and replication. Zika virus E/Envelope Protein (Domain I, His-MBP) is the recombinant Virus-derived Zika virus E/Envelope protein, expressed by E. coli , with N-His, N-MBP labeled tag. Zika virus E/Envelope Protein (Domain I, His-MBP), has molecular weight of ~57.2 kDa.
Genome polyprotein is a smaller protein chain of covalent linkages that is a key component of virus survival and replication. Zika virus E/Envelope Protein (Biotinylated, HEK293, His) is the recombinant Virus-derived Zika virus E/Envelope protein, expressed by HEK293 , with C-His labeled tag. The total length of Zika virus E/Envelope Protein (Biotinylated, HEK293, His) is 107 a.a., with molecular weight of ~13 kDa.
The NS1 protein plays a key role in viral budding, association with cell membranes, and facilitating the assembly of viral RNA into nucleocapsids to form mature viral particles. During entry, NS1 induces genome penetration into the host cytoplasm. E/Envelope Protein, Dengue virus 1 (101a.a, HEK293, His) is the recombinant Virus-derived E/Envelope protein, expressed by HEK293 , with C-His labeled tag. The total length of E/Envelope Protein, Dengue virus 1 (101a.a, HEK293, His) is 101 a.a., with molecular weight of ~12.4 kDa.
Genome polyprotein is a smaller protein chain of covalent linkages that is a key component of virus survival and replication. Zika virus E/Envelope Protein (107a.a, sf9, His) is the recombinant Virus-derived Zika virus E/Envelope protein, expressed by Sf9 insect cells , with C-His labeled tag. The total length of Zika virus E/Envelope Protein (107a.a, sf9, His) is 107 a.a., with molecular weight of ~13 kDa.
Genome polyprotein is a smaller protein chain of covalent linkages that is a key component of virus survival and replication. Zika virus E/Envelope Protein (107a.a, HEK293, Fc) is the recombinant Virus-derived Zika virus E/Envelope protein, expressed by HEK293 , with C-hFc labeled tag. The total length of Zika virus E/Envelope Protein (107a.a, HEK293, Fc) is 107 a.a., with molecular weight of ~38.2 kDa.
The large envelope protein has two conformations: “external” (Le-HBsAg) and “internal” (Li-HBsAg). In its external state, it mediates viral attachment, initiates infection, determines species specificity, and promotes viral particle internalization via caveolin-mediated endocytosis. Large envelope Protein, HBV-D (Cell-Free, His) is the recombinant Virus-derived Large envelope protein, expressed by E. coli Cell-free , with N-10*His labeled tag. The total length of Large envelope Protein, HBV-D (Cell-Free, His) is 388 a.a., with molecular weight of Monomer:40 kDa
Dimer:80 kDa.
The large envelope protein exhibits two topological conformations: “external” (Le-HBsAg) and “internal” (Li-HBsAg). In the external state, it attaches the virus to cellular receptors, initiating infection and determining liver tropism. Large envelope Protein, HBV-A (Cell-Free, P03141, His) is the recombinant Virus-derived Large envelope protein, expressed by E. coli Cell-free , with N-10*His labeled tag. The total length of Large envelope Protein, HBV-A (Cell-Free, P03141, His) is 399 a.a., with molecular weight of 45.1 kDa.
Large envelope proteins exist in two topological conformations: “external” (Le-HBsAg) and “internal” (Li-HBsAg). In its external state, it mediates viral attachment to cellular receptors, initiates infection, determines species specificity, and promotes viral particle internalization via caveolin-mediated endocytosis. Large envelope Protein, HBV-A (Cell-Free, P17101, His) is the recombinant Virus-derived Large envelope protein, expressed by E. coli Cell-free , with N-10*His labeled tag. The total length of Large envelope Protein, HBV-A (Cell-Free, P17101, His) is 399 a.a., with molecular weight of 45.1 kDa.
The large envelope protein is crucial in its two conformations, "outside" (Le-HBsAg) and "inside" (Li-HBsAg). Externally, it binds the virus to cellular receptors, initiates infection, determines species specificity, and promotes viral particle internalization via caveolin-mediated endocytosis. Large envelope Protein, HBV-C (P.pastoris, 180a.a, His) is the recombinant Virus-derived Large envelope protein, expressed by P. pastoris , with N-6*His labeled tag. The total length of Large envelope Protein, HBV-C (P.pastoris, 180a.a, His) is 180 a.a., with molecular weight of 20.9 kDa.
Genome polyprotein is a smaller protein chain of covalent linkages that is a key component of virus survival and replication. Zika virus E/Envelope Protein (97a.a, HEK293, Fc) is the recombinant Virus-derived Zika virus E/Envelope protein, expressed by HEK293 , with C-hFc labeled tag. The total length of Zika virus E/Envelope Protein (97a.a, HEK293, Fc) is 97 a.a., with molecular weight of ~36.7 kDa.
Genome polyprotein is a smaller protein chain of covalent linkages that is a key component of virus survival and replication. Zika virus E/Envelope Protein (T366A, Q367G, W391R, L397R, sf9, His) is the recombinant Virus-derived Zika virus E/Envelope protein, expressed by Sf9 insect cells , with C-His labeled tag. The total length of Zika virus E/Envelope Protein (T366A, Q367G, W391R, L397R, sf9, His) is 406 a.a., with molecular weight of ~45.6 kDa.
The NS1 protein plays a key role in viral budding, association with cell membranes, and facilitating the assembly of viral RNA into nucleocapsids to form mature viral particles. During entry, NS1 induces genome penetration into the host cytoplasm. E/Envelope Protein, Dengue virus 4 (395a.a, sf9, His) is the recombinant Virus-derived E/Envelope protein, expressed by Sf9 insect cells , with C-His labeled tag. The total length of E/Envelope Protein, Dengue virus 4 (395a.a, sf9, His) is 395 a.a., with molecular weight of ~44.8 kDa.
The NS1 protein plays a key role in viral budding, association with cell membranes, and facilitating the assembly of viral RNA into nucleocapsids to form mature viral particles. During entry, NS1 induces genome penetration into the host cytoplasm. E/Envelope Protein, Dengue virus 4 (101a.a, HEK293, His) is the recombinant Virus-derived E/Envelope protein, expressed by HEK293 , with C-His labeled tag. The total length of E/Envelope Protein, Dengue virus 4 (101a.a, HEK293, His) is 101 a.a., with molecular weight of ~12.41 kDa.
The NS1 protein plays a key role in viral budding, association with cell membranes, and facilitating the assembly of viral RNA into nucleocapsids to form mature viral particles. During entry, NS1 induces genome penetration into the host cytoplasm. E/Envelope Protein, Dengue virus 3 (429a.a, HEK293, His) is the recombinant Virus-derived E/Envelope protein, expressed by HEK293 , with C-His labeled tag. The total length of E/Envelope Protein, Dengue virus 3 (429a.a, HEK293, His) is 429 a.a., with molecular weight of ~48.79 kDa.
